Brokers International Adds AuguStar Life to Carrier Line-Up

Brokers International is pleased to announce a dynamic addition to our carrier line-up with the partnership of A-rated AuguStarSM Life. This means you have access to a suite of life insurance choices right for a wide range of individual family needs and crucial business protection.

Our new relationship with AuguStar Life (formerly Ohio National Financial Services) is now being offered to BI’s network of agencies and financial professionals.

AuguStar is focusing on further expanding the role of life insurance in protecting the financial health of individuals, families, and businesses through life’s predictable and unpredictable events. Products include:

  • Indexed universal life—to protect loved ones, grow wealth, and create tax advantages
  • Indexed whole life—life-long insurance protection, level premiums and death benefits, and tax-smart cash value that earns interest based on an investment index
  • Term life—for death benefits guaranteed throughout a specific period, premiums based on insured’s age, health, and life expectancy, and possible renewal and conversion

Reach out to your Cornerstone Senior Marketing Sales Rep to receive more information to help you assess your existing clients’ needs and consider new market segments and people who may need your financial expertise.  614-763-2255

CMS Releases Revised Guidance for Medicare Prescription Drug Inflation Rebate Program

December 14, 2023

Contact: CMS Media Relations
CMS Media Inquiries

FOR IMMEDIATE RELEASE
December 14, 2023Contact: CMS Media Relations
CMS Media Inquiries

 

CMS Releases Revised Guidance for Medicare Prescription Drug Inflation Rebate Program 

Under President Biden’s lower-cost prescription drug law, drug companies will pay rebates to Medicare for raising prescription drug prices faster than the rate of inflation

 

As a result of President Biden’s historic prescription drug law, the Inflation Reduction Act, drug companies will pay rebates to Medicare when prices of certain prescription drugs administered or dispensed to people with Medicare increase faster than the rate of inflation. In addition, people with Medicare may pay a lower coinsurance for some Part B drugs if the drugs’ prices increase faster than the rate of inflation.

Today, the Centers for Medicare & Medicaid Services (CMS) released revised guidance detailing key requirements and procedures for calculating rebates and invoicing manufacturers that owe rebates to Medicare under the Medicare Prescription Drug Inflation Rebate Program for certain drugs covered under Medicare Part B and Part D. CMS also released the list of 48 prescription drugs for which Part B beneficiary coinsurances may be lower between January 1, 2024 – March 31, 2024. Some people with Medicare who take these drugs may save between $1 and $2,786 per average dose starting January 1, 2024, depending on their individual coverage.

“The Inflation Reduction Act is making health care and prescription drugs more affordable while improving the sustainability of the Medicare program,” said CMS Administrator Chiquita Brooks-LaSure. “The Medicare Prescription Drug Inflation Rebate Program is an important tool to discourage excessive price increases and protect people with Medicare, and today’s revised guidance for the Inflation Rebate Program finalizes key requirements and outlines the process by which CMS will calculate and invoice inflation rebates beginning in 2025.”

When drug companies of certain drugs covered under Medicare Part B and Part D raise prices at a rate that exceeds the rate of inflation, these drug companies will pay rebates to the Medicare Trust Fund under the Medicare Prescription Drug Inflation Rebate Program. CMS will issue invoices to drug companies for these rebates starting in 2025, including for years 2022, 2023, and 2024. The Part D inflation rebate period began on October 1, 2022, and the Part B inflation rebate period began on January 1, 2023. In addition, CMS will continue to apply lower beneficiary coinsurances for certain Part B drugs if prices increase faster than inflation. Including the drugs announced today, CMS has lowered coinsurance for 64 drugs and biologicals.

CMS issued initial guidance on the Medicare Prescription Drug Inflation Rebate Program in February 2023 and voluntarily sought public comment on key topics. The agency received and analyzed more than 90 comments on the initial guidance from consumer and patient groups, drug companies, and other interested parties.

CMS gathered feedback on how best to address challenges drug companies are facing due to likely or actual drug shortages and severe supply chain disruptions, particularly for events outside of their control, and provides for appropriate reduced rebate amounts consistent with the Inflation Reduction Act. The revised guidance also includes guardrails to minimize incentives for drug companies to remain on a shortage list, delay resolving a severe supply chain disruption, or maintain a situation in which a generic drug would be at risk of shortage in order to avoid paying an inflation rebate. While the inflation rebates do not apply to multi-source generic drugs, which are the drugs most likely to be in shortage, the revised guidance provides a greater rebate reduction for Part D sole-source generic drugs as well as Part B and Part D plasma-derived products in shortage.

“Today’s guidance strikes a balance between discouraging large price increases by drug companies and providing appropriate relief to drug companies experiencing shortages or severe supply chain disruptions,” said Dr. Meena Seshamani, M.D., Ph.D., CMS Deputy Administrator and the Director of the Center for Medicare. “Our goal at CMS is to make sure drugs are more affordable and accessible, which includes helping to safeguard and ensure that the pharmaceutical supply chain can deliver critical medicines to providers and patients.”

Key dates for implementing the Medicare Prescription Drug Inflation Rebate Program include:

  • October 1, 2022: Began the first 12-month period for which drug companies will be required to pay rebates to Medicare for raising prices that outpace inflation on certain Part D drugs.
  • January 1, 2023: Began the first quarterly period for which drug companies will be required to pay rebates for raising prices that outpace inflation on certain Part B drugs.
  • April 1, 2023: Some people with Traditional Medicare and Medicare Advantage started paying a lower coinsurance for certain Part B drugs with prices increasing at a rate faster than inflation.
  • 2025: CMS intends to send the first invoices to drug companies for the rebates owed.

View a fact sheet on the Medicare Prescription Drug Inflation Rebate Program revised guidance.

Read the Medicare Part B Prescription Drug Inflation Rebate revised guidance.

Read the Medicare Part D Prescription Drug Inflation Rebate revised guidance.

The lower Part B coinsurance on the list of drugs will be in effect from January 1, 2024, to March 31, 2024. This coinsurance adjustment applies to certain drugs and biologicals paid under Medicare Part B. The Part B drugs impacted by this coinsurance adjustment may change quarterly.

More information about these 48 Part B drugs and biological products can be found in the quarterly Average Sales Price (ASP) public files, available here. A fact sheet is available here.

View an ASPE fact sheet on prescription drugs with reduced coinsurances in 2023.

 

###

Devoted’s 2024 Star Ratings for Ohio are Confirmed

Press Contact
devoted@crosscutstrategies.com

Devoted Health Achieves 5 out of 5 Medicare Advantage Star

Rating for Florida and Ohio HMO Plans
94 percent of Devoted members in rated plans are enrolled in 4-Star plans or higher

 

 

Anthem’s NEW RTS Screen on Producer Toolbox – Great Resource!

Sourced from Anthem broker email communication:

On July 15, 2023, the Producer Toolbox will introduce a new Ready to Sell (RTS) page that allows brokers to view their RTS status for each state they intend to sell Medicare products.

Brokers will easily be able to see if they are licensed, certified, and appointed with each state – as well as complete any outstanding components they may have.

If you have any questions, please reach out to service@cornerstoneseniormarketing.com 

Anthem: Talk Desk Discontinued as of March 20, 2023

Talk Desk is being discontinued as a tool for recording telephonic scope of appointments and voice signatures. This change comes about due to the CMS implemented requirements of recording all pre-enrollment and post-enrollment calls to prospects and current members.

Additionally, Medicare Voice Signature Services is a new tool that is now available in Producer Toolbox. This tool is only available to use during a face-to-face appointment when the applicant is unable to physically or electronically sign the SOA or enrollment application and does not have a Power of Attorney representative present. The below Quick Reference Guide provides the steps for using the Medicare Voice Signature Service.

Medicare Voice Signature Services Quick Guide – PDF

  • As a reminder, all calls with prospects and current members must be recorded and stored in a HIPAA compliant manner according to the CMS requirements implemented in October 2022. This includes all pre-enrollment calls and post-enrollment calls.
  • By recording all calls, the requirements for recording telephonic scope of appointment and voice signature during enrollment are also fulfilled. It is not necessary to record a telephonic scope of appointment or voice signature separately.
  • Talk Desk, the tool used for recording a telephonic scope of appointment and voice signature, will be discontinued as of March 20, 2023.
  • Historical Talk Desk recordings will continue to be accessible in the Portal.

 

Questions?  Please contact your CSM rep

 

AEP 2023 Reminder: Last Day for 2023 AEP Enrollments

AEP Ends Wednesday, December 7, 2022

 

Important information about the last days of AEP and submitting enrollment applications

The following tips will help ensure your hard work this AEP pays off and your applications are processed correctly, including those submitted on Wednesday, December 7, 2022.

  • AEP application submission deadline: ALL applications must be submitted no later than 11:59 pm on December 7, 2022.
  • Date the application.  It is important to include a date on every enrollment application.  Applications without a date, received after December 7, 2022, are assigned the date the application was received by the carrier, which can invalidate apps received after AEP ends.  Apps that you received on December 7, 2022, must be submitted to the carrier, dated December 7, 2022.
  • Faxing Applications:  If faxing the application, remember to keep a copy of your successful fax transmittal as confirmation of submission.
App Submission Guide
2023 AEP Tips & Guidance

Cigna’s VBE Program – Pays more for digital applications

It’s easy to make additional money with Cigna Medicare! Follow the steps below to earn up to $50 on every enrollment!

  1. Submit your new-to-Cigna application digitally and earn $20 per eligible approved application.
  2. Include a valid in-network PCP on the digital application and earn an additional $20.
  3. Include a valid customer email address on the digital application and earn an additional $10.

Eligible plans:

  • All Cigna MAPD plans are eligible for the additional VBE payments. 

Agent training qualifications:

  • Agents must complete all required training in order to be certified and ready to sell 2023 Cigna MAPD plans.
  • No additional VBE training modules are required.

Qualified digital applications:

  • Connecture (DRx)
  • Sunfire
  • eEnrollment
  • OEC files

Valid customer email addresses:

  • Agents must provide a unique and valid email address for the customer.
  • Generic email addresses or an agent’s personal/business email address will not be accepted.
  • Valid PCPs:
    • The provider must be in-network to qualify for the additional VBE payment. Out-of-network providers will not qualify for the additional VBE payment.
    • PCP information must be valid and correct. Incorrect information will not qualify for the additional VBE payment.

Application status:

  • Agents can view their application status in com.
  • Please note: The application status will not inform if the application qualifies for the VBE program payments.

Commissions statement:

  • “VBE – Digital Admin Fee” will be included in the Adjustment Notes column of the commissions statement.
  • The line item will indicate the name of the customer, so agents can verify that they have been paid for each successfully completed and eligible digital application.
Don’t forget about our health risk assessment (HRA) incentive!

 

·    Earn $125 when you enroll your Cigna Medicare Advantage customers in an eligible Medicare D-SNP or C-SNP plan and facilitate an HRA. (For 2023 effectives)

·    Earn $75 for each HRA that you facilitate with your other Cigna Medicare Advantage customers.

 

This means even more money in your pocket! Click here to learn more about Cigna’s HRA incentive.

Mutual of Omaha: Now Offering a Third PDP Plan for 2023

Just in time for the Medicare Annual Enrollment Period, the Mutual of Omaha RxSM Essential (PDP) plan joins MOO’s lineup of two existing prescription drug plans to provide more options for senior-age customers. The new plan has low monthly premiums and is ideal for newly eligible Medicare-age individuals who typically don’t use a lot of medications or for people on low-cost medications.

 

Don’t forget — before producers can discuss the benefits of prescription drug plans with their clients, they must meet one of the following ready to sell requirements:

• Successfully complete AHIP’s 2023 Medicare and Fraud, Waste and Abuse Training AND the 2023 Mutual of Omaha Rx Product Training.
• Successfully complete the 2023 Mutual of Omaha Rx Compliance Training AND the 2023 Mutual of Omaha Rx Product Training.

 

LEARN MORE ABOUT THE PDP PLANS HERE

2023 Medicare Parts A & B Premiums and Deductibles 2023 Medicare Part D Income-Related Monthly Adjustment Amounts

On September 27, 2022, the Centers for Medicare & Medicaid Services (CMS) released the 2023 premiums, deductibles, and coinsurance amounts for the Medicare Part A and Part B programs, and the 2023 Medicare Part D income-related monthly adjustment amounts.

Medicare Part B Premium and Deductible Medicare Part B covers physician services, outpatient hospital services, certain home health services, durable medical equipment, and certain other medical and health services not covered by Medicare Part A. Each year the Medicare Part B premium, deductible, and coinsurance rates are determined according to the Social Security Act. The standard monthly premium for Medicare Part B enrollees will be $164.90 for 2023, a decrease of $5.20 from $170.10 in 2022. The annual deductible for all Medicare Part B beneficiaries is $226 in 2023, a decrease of $7 from the annual deductible of $233 in 2022.

The 2022 premium included a contingency margin to cover projected Part B spending for a new drug, Aduhelm. Lower-than-projected spending on both Aduhelm and other Part B items and services resulted in much larger reserves in the Part B account of the Supplementary Medical Insurance (SMI) Trust Fund, which can be used to limit future Part B premium increases. The decrease in the 2023 Part B premium aligns with the CMS recommendation in a May 2022 report that excess SMI reserves be passed along to people with Medicare Part B coverage.

Beginning in 2023, certain Medicare enrollees who are 36 months post kidney transplant, and therefore are no longer eligible for full Medicare coverage, can elect to continue Part B coverage of immunosuppressive drugs by paying a premium. For 2023, the immunosuppressive drug premium is $97.10.

Medicare Open Enrollment and Medicare Savings Programs

Medicare Open Enrollment for 2023 will begin on October 15, 2022 and ends on December 7, 2022. During this time, people eligible for Medicare can compare 2023 coverage options between Original Medicare, and Medicare Advantage, and Part D prescription drug plans. In addition to the soon-to-be released premiums and cost sharing information for 2023 Medicare Advantage and Part D plans, the Fee-for-Service Medicare premiums and cost sharing information released today will enable people with Medicare to understand their Medicare coverage options for the year ahead. Medicare health and drug plan costs and covered benefits can change from year to year, so people with Medicare should look at their coverage choices annually and decide on the options that best meet their health needs.

To help with their Medicare costs, low-income seniors and adults with disabilities may qualify to receive financial assistance from the Medicare Savings Programs (MSPs). The MSPs help millions of Americans access high-quality health care at a reduced cost, yet only about half of eligible people are enrolled. The MSPs help pay Medicare premiums and may also pay Medicare deductibles, coinsurance, and copayments for those who meet the conditions of eligibility. Enrolling in an MSP offers relief from these Medicare costs, allowing people to spend that money on other vital needs, including food, housing, or transportation. People with Medicare interested in learning more can visit: https://www.medicare.gov/your-medicare-costs/get-help-paying-costs/medicare-savings-programs.

Medicare Part B Income-Related Monthly Adjustment Amounts

Since 2007, a beneficiary’s Part B monthly premium is based on his or her income. These income-related monthly adjustment amounts affect roughly 7 percent of people with Medicare Part B. The 2023 Part B total premiums for high-income beneficiaries with full Part B coverage are shown in the following table:

Full Part B Coverage
Beneficiaries who file individual tax returns with modified adjusted gross income: Beneficiaries who file joint tax returns with modified adjusted gross income: Income-Related Monthly Adjustment Amount Total Monthly

 Premium Amount

Less than or equal to $97,000 Less than or equal to $194,000 $0.00 $164.90
Greater than $97,000 and less than or equal to $123,000 Greater than $194,000 and less than or equal to $246,000 $65.90 $230.80
Greater than $123,000 and less than or equal to $153,000 Greater than $246,000 and less than or equal to $306,000 $164.80 $329.70
Greater than $153,000 and less than or equal to $183,000 Greater than $306,000 and less than or equal to $366,000 $263.70 $428.60
Greater than $183,000 and less than $500,000 Greater than $366,000 and less than $750,000 $362.60 $527.50
Greater than or equal to $500,000 Greater than or equal to $750,000 $395.60 $560.50

The 2023 Part B total premiums for high-income beneficiaries with immunosuppressive drug only Part B coverage are shown in the following table:

Part B Immunosuppressive Drug Coverage Only
Beneficiaries who file individual tax returns with modified adjusted gross income: Beneficiaries who file joint tax returns with modified adjusted gross income: Income-Related Monthly Adjustment Amount Total Monthly

 Premium Amount

Less than or equal to $97,000 Less than or equal to $194,000 $0.00 $97.10
Greater than $97,000 and less than or equal to $123,000 Greater than $194,000 and less than or equal to $246,000 $64.70 $161.80
Greater than $123,000 and less than or equal to $153,000 Greater than $246,000 and less than or equal to $306,000 $161.80 $258.90
Greater than $153,000 and less than or equal to $183,000 Greater than $306,000 and less than or equal to $366,000 $258.90 $356.00
Greater than $183,000 and less than $500,000 Greater than $366,000 and less than $750,000 $356.00 $453.10
Greater than or equal to $500,000 Greater than or equal to $750,000 $388.40 $485.50

Premiums for high-income beneficiaries with full Part B coverage who are married and lived with their spouse at any time during the taxable year, but file a separate return, are as follows:

Full Part B Coverage
Beneficiaries who are married and lived with their spouses at any time during the year, but who file separate tax returns from their spouses, with modified adjusted gross income: Income-Related Monthly Adjustment Amount Total Monthly Premium Amount
Less than or equal to $97,000 $0.00 $164.90
Greater than $97,000 and less than $403,000 $362.60 $527.50
Greater than or equal to $403,000 $395.60 $560.50

Premiums for high-income beneficiaries with immunosuppressive drug only Part B coverage who are married and lived with their spouse at any time during the taxable year, but file a separate return, are as follows:

Part B Immunosuppressive Drug Coverage Only
Beneficiaries who are married and lived with their spouses at any time during the year, but who file separate tax returns from their spouses, with modified adjusted gross income: Income-Related Monthly Adjustment Amount Total Monthly Premium Amount
Less than or equal to $97,000 $0.00 $97.10
Greater than $97,000 and less than $403,000 $356.00 $453.10
Greater than or equal to $403,000 $388.40 $485.50

Medicare Part A Premium and Deductible

Medicare Part A covers inpatient hospital, skilled nursing facility, hospice, inpatient rehabilitation, and some home health care services. About 99 percent of Medicare beneficiaries do not have a Part A premium since they have at least 40 quarters of Medicare-covered employment.

The Medicare Part A inpatient hospital deductible that beneficiaries pay if admitted to the hospital will be $1,600 in 2023, an increase of $44 from $1,556 in 2022. The Part A inpatient hospital deductible covers beneficiaries’ share of costs for the first 60 days of Medicare-covered inpatient hospital care in a benefit period. In 2023, beneficiaries must pay a coinsurance amount of $400 per day for the 61st through 90th day of a hospitalization ($389 in 2022) in a benefit period and $800 per day for lifetime reserve days ($778 in 2022). For beneficiaries in skilled nursing facilities, the daily coinsurance for days 21 through 100 of extended care services in a benefit period will be $200.00 in 2023 ($194.50 in 2022).

Part A Deductible and Coinsurance Amounts for Calendar Years 2022 and 2023
by Type of Cost Sharing
  2022 2023
Inpatient hospital deductible $1,556 $1,600
Daily coinsurance for 61st-90th Day $389 $400
Daily coinsurance for lifetime reserve days $778 $800
Skilled Nursing Facility coinsurance $194.50 $200.00

Enrollees age 65 and over who have fewer than 40 quarters of coverage and certain persons with disabilities pay a monthly premium in order to voluntarily enroll in Medicare Part A. Individuals who had at least 30 quarters of coverage or were married to someone with at least 30 quarters of coverage may buy into Part A at a reduced monthly premium rate, which will be $278 in 2023, a $4 increase from 2022. Certain uninsured aged individuals who have less than 30 quarters of coverage and certain individuals with disabilities who have exhausted other entitlement will pay the full premium, which will be $506 a month in 2023, a $7 increase from 2022.

For more information on the 2023 Medicare Parts A and B premiums and deductibles Notices (CMS-8080-N, CMS-8081-N, CMS-8082-N), please visit:

CMS-8080-N: https://www.federalregister.gov/public-inspection/2022-21180/medicare-program-calendar-year-2023-inpatient-hospital-deductible-and-hospital-and-extended-care

CMS-8081-N:https://www.federalregister.gov/public-inspection/2022-21176/medicare-program-cy-2023-part-a-premiums-for-the-uninsured-aged-and-for-certain-disabled-individuals

CMS-8082-N:https://www.federalregister.gov/public-inspection/2022-21090/medicare-program-medicare-part-b-monthly-actuarial-rates-premium-rates-and-annual-deductible

Medicare Part D Income-Related Monthly Adjustment Amounts

Since 2011, higher income beneficiaries’ Part D monthly premiums are based on income. These income-related monthly adjustment amounts affect roughly 8 percent of people with Medicare Part D. These individuals will pay the income-related monthly adjustment amount in addition to their Part D premium. Part D premiums vary from plan to plan and roughly two-thirds of beneficiaries pay premiums directly to the plan, while the remaining beneficiaries have their premiums deducted from their Social Security benefit checks. Regardless of how a beneficiary pays their Part D premium, the Part D income-related monthly adjustment amounts are deducted from Social Security benefit checks or paid directly to Medicare. The 2023 Part D income-related monthly adjustment amounts for high-income beneficiaries are shown in the following table:

Beneficiaries who file individual tax returns with modified adjusted gross income: Beneficiaries who file joint tax returns with modified adjusted gross income: Income-related monthly adjustment amount
Less than or equal to $97,000 Less than or equal to $194,000 $0.00
Greater than $97,000 and less than or equal to $123,000 Greater than $194,000 and less than or equal to $246,000 12.20
Greater than $123,000 and less than or equal to $153,000 Greater than $246,000 and less than or equal to $306,000 31.50
Greater than $153,000 and less than or equal to $183,000 Greater than $306,000 and less than or equal to $366,000 50.70
Greater than $183,000 and less than $500,000 Greater than $366,000 and less than $750,000 70.00
Greater than or equal to $500,000 Greater than or equal to $750,000 76.40

Premiums for high-income beneficiaries who are married and lived with their spouse at any time during the taxable year, but file a separate return, are as follows:

Beneficiaries who are married and lived with their spouses at any time during the year, but file separate tax returns from their spouses, with modified adjusted gross income: Income-related monthly adjustment amount
Less than or equal to $97,000 $0.00
Greater than $97,000 and less than $403,000 70.00
Greater than or equal to $403,000 76.40

CMS Marketing Changes

The marketing guidelines for Medicare Advantage and Prescription Drug Plans were updated on May 9, 2022. Among the provisions that apply directly to agents, the two most critical, which are to be in use by October 1, 2022, for Plan Year 2023, are a new required disclaimer and a requirement to record all sales calls with beneficiaries. While not comprehensive, the FAQ’s below will provide details. 

Required Disclaimer 

Disclaimer Language To Use:

“We do not offer every plan available in your area. Any information we provide is limited to those plans we do offer in your area. Please contact Medicare.gov or 1-800-MEDICARE to get information on all of your options.” 

Who must use this disclaimer?

Any third-party marketing organization (which includes agents and brokers) must include this disclaimer. 

When and where do I have to have the disclaimer?

  • On all marketing materials: print (if possible, use a 12pt font), electronically, television, and radio
  • Within the first minute of all sales calls
  • Prominently displayed on TPMO websites
  • Verbally, electronically, or in writing, during any sales meeting with a beneficiary

What if I DO offer all plans in my area? 

While the regulation does provide a carve-out for TPMO’s that truly offer all plans in their area, it is exceedingly rare for an agent to truly be able to do this. In most areas, there are one or more plans that are offered only through captive agents, direct to consumer, or certain types of plans that agents and brokers cannot sell. Even if you do offer all plans in one county or service area, it is possible your marketing or referrals may extend to an area where that is not true, so the disclaimer would still be required. 

Requirement to Record Sales Calls

Under these new guidelines, all sales calls with beneficiaries and TPMO’s MUST be recorded and retained for 10 years, including enrollment calls. 

What constitutes a sales call? 

Any call that is related to what CMS calls the “chain of enrollment,” which has been defined as the events from a beneficiary becoming aware of an MA/PDP plan to the end of the enrollment process. This means that calling leads, scheduling appointments, collecting scopes of appointment (telephonically), presenting plans, collecting drug and doctor lists, and phone enrollments would all fall under this guidance. This list is not exhaustive, and other calls that contain marketing content will also need to be recorded and retained. 

How can I record and store calls? 

We recommend reaching out to your current phone provider to see if they offer call recording. If they do not, or it seems cost prohibitive, consider a VOIP phone system that can be used in the office or the field. Some common options are Ring Central, 8×8, and Vonage. For storage, you will need to develop a process for sorting and storing the calls either on a local drive or cloud-based storage. Since these calls contain sensitive data, most free storage accounts will not be HIPAA compliant. We are currently researching the best options for agents to compliantly store this data. 

What about in person appointments? 

In-person marketing and sales appointments do not need to be recorded, however, calls to set appointments or follow-up calls to answer benefit questions would require recording. Servicing questions about current plan business, such as claims, billing, and requesting in force plan documents, are not sales calls and would not require recording. 

I use my cell phone. How can I handle this? 

Most VOIP services have a mobile app version that would allow calls to be recorded from your mobile device. There are also recording apps that would allow for recording calls without VOIP. Be cautioned, however, as a stand-alone recording app will not include any disclaimers that may be required by your jurisdiction before recording, whereas most VOIP systems offer/include these options.

Please reach out with any questions to your team at Cornerstone Senior Marketing.  (614) 763-2255 |  compliance@cornerstoneseniormarketing.comquirement to Record Sales Calls